Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The GLACE Study: Evaluating CLAAS With ICE Guided LAA Closure

NCT: NCT06580275 · COMPLETED

NCT IDNCT06580275
StatusCOMPLETED
Start Date2024-09-24
Completion2026-09-08
SponsorConformal Medical, Inc (INDUSTRY)
First posted
Last updated

Brief Summary

The CLAAS® device will be evaluated for safety and performance in the reduction of stroke in subjects with non-valvular atrial fibrillation under intracardiac echocardiography (ICE) imaging for left atrial appendage closure.

Frequently Asked Questions

What is The GLACE Study: Evaluating CLAAS With ICE Guided LAA Closure?

The GLACE Study: Evaluating CLAAS With ICE Guided LAA Closure is a clinical trial registered under NCT06580275. Current status: COMPLETED.

What is the status of NCT06580275?

The current status of NCT06580275 (The GLACE Study: Evaluating CLAAS With ICE Guided LAA Closure) is: COMPLETED.

When did The GLACE Study: Evaluating CLAAS With ICE Guided LAA Closure start?

The GLACE Study: Evaluating CLAAS With ICE Guided LAA Closure started on 2024-09-24.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑